Bofanglutide
Phase III Clinical Study Comparing the Efficacy and Safety of GZR18 Injection and Semaglutide (Wegovy®) in Adult Obese or Overweight Subjects
Gan & Lee Pharmaceuticals · Phase 3 · Recruiting · Enrollment 420
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.